Aragwadha
Cassia fistula L.
Aragwadha (Cassia fistula L.) is a plant used in Ayurveda, from the Fabaceae (Caesalpinioideae) family. Included in Ayurvedic Pharmacopoeia of India; WHO-related traditional medicine databases reference its widespread use across tropical Asia and Africa.
| Botanical name | Cassia fistula L. |
|---|---|
| Family | Fabaceae (Caesalpinioideae) · other entries in this family |
| Order | Fabales |
| Pharmacopoeia status | Included in Ayurvedic Pharmacopoeia of India; WHO-related traditional medicine databases reference its widespread use across tropical Asia and Africa |
| Taxon identifiers | GBIF 5357108 · Wikidata Q161117 · NCBI Taxonomy 53852 |
Names and identification
| Language | Name |
|---|---|
| English | Aragwadha |
| Latin/Botanical | Cassia fistula L. |
Key Phytochemical Constituents
- Rhein (anthraquinone)
- Emodin
- Fistulic acid
- Sennosides A-D
- Quercetin
- Kaempferol
- Oxyanthraquinone
- Catechin
How does it work?
- Laxative: Sennosides and anthraquinone glycosides stimulate colonic peristalsis by increasing Cl- secretion and inhibiting Na+/K+-ATPase in colonocytes
- Anti-inflammatory: Rhein and emodin suppress NF-kB activation and reduce COX-2 expression in inflammatory cells
- Antidiabetic: Flavonoids (quercetin, kaempferol) inhibit alpha-amylase and alpha-glucosidase, reducing postprandial glycemic spikes
Which traditional uses are supported by research?
- Mild laxative (Mridu Virechana) validated by clinical trial showing comparable efficacy to lactulose in geriatric constipation
- Skin disease treatment confirmed by antimicrobial and antifungal activity of leaf and bark extracts against dermatophytes
- Antipyretic use (Jwaraghna) supported by significant fever reduction in Brewer’s yeast-induced pyrexia model
What do recent clinical trials show?
3 further claims previously listed here could not be traced to a published paper and have been removed. An absence here means we could not identify the source, not that no work exists.
Recent safety updates
- Pod pulp is safe as a mild laxative at standard doses (LD50 > 5000 mg/kg in rodents); long-term high-dose anthraquinone use may cause melanosis coli
- Not recommended during pregnancy due to uterine stimulant potential; chronic use may cause electrolyte imbalance (hypokalemia)
What is it made of?
Key Active Markers
- Rhein
- Emodin
- Quercetin
- Kaempferol
- Catechin
- Fistulic acid
- Sennosides A-D
- Oxyanthraquinone
Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)
Dosage forms and preparation
Dosage Forms: Pulp extract (fruit pulp), Kashayam (decoction), Churna (powder), Capsule, Tablet, Lepa (paste for skin conditions), Aragwadhadi Kwatha
Standard Dosage: 5-10g fruit pulp; 50-100ml decoction twice daily; 3-6g powder for mild laxative action; external paste as needed
Bioavailability: Moderate to good bioavailability. Cassia fistula fruit pulp contains anthraquinone glycosides (rhein, sennoside-like compounds) that pass through the small intestine largely intact and are activated by colonic bacterial beta-glucosidases — classical prodrug mechanism for laxative action. Free anthraquinones are absorbed in the small intestine. Fistulic acid and other organic acids are well absorbed.
Optimal Timing: At bedtime with warm water or warm milk for laxative effect; morning empty stomach for skin conditions (internal detox); external paste anytime
Standardized Extract: Fruit pulp extract standardized to minimum 2% total anthraquinones (as rhein equivalent). Bark extract standardized to minimum 3% total polyphenols. Fistulic acid content minimum 0.5%.
Shelf Life: 2 years (powder/spray-dried pulp); 3 years (capsules/tablets); 6 months (fresh pulp extract, preserved); 18 months (decoction concentrate)
Storage: Hygroscopic material — moisture-proof packaging essential. Cool, dry place below 25°C. Pods can be stored whole for up to 1 year at room temperature.
Marker Compounds: Rhein, Fistulic acid, Sennosides (trace), Chrysophanol, Kaempferol, Oxyanthraquinones, Fistucacidin
Extraction Methods
- Direct fruit pulp extraction (aqueous maceration)
- Aqueous decoction of pods/bark
- Hydroalcoholic extraction (50:50) for anthraquinone standardization
- Methanol extraction for flavonoid enrichment
Synergistic Combinations
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Systematic reviews and meta-analyses2
- 2022. Nonpharmacologic Treatment for Children with Functional Constipation: A Systematic Review and Meta-analysisThe Journal of pediatrics. PMID 34536492 · doi:10.1016/j.jpeds.2021.09.010
- 2021. The medicinal properties of Cassia fistula L: A reviewBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. PMID 34601194 · doi:10.1016/j.biopha.2021.112240
Randomised controlled trials2
- 2022. The effect of Cassia fistula L. syrup in geriatrics constipation in comparison with the lactulose: A randomized clinical trialJournal of ethnopharmacology. PMID 35798138 · doi:10.1016/j.jep.2022.115466
- 2018. A randomized comparative study of herbal decoction of Cassia fistula Linn pod's pericarp and Myristica fragrans Houtt arils vs. mefenamic acid in spasmodic dysmenorrhoeaJournal of complementary & integrative medicine. PMID 30312165 · doi:10.1515/jcim-2018-0105
Other clinical studies and reviews8
- 2024. The Role of Nutrition in the Pathogenesis and Treatment of Autoimmune Bullous Diseases-A Narrative ReviewNutrients. PMID 39599747 · doi:10.3390/nu16223961
- 2023. The Importance of Traditional Chinese Medicine in the Intervention and Treatment of HIV while Considering its Safety and EfficacyCurrent HIV research. PMID 38047360 · doi:10.2174/011570162X271199231128092621
- 2021. Therapeutic Potential of Natural Products in Treatment of Cervical Cancer: A ReviewNutrients. PMID 33466408 · doi:10.3390/nu13010154
- 2020. Progress and prospects in the management of bacterial infections and developments in Phytotherapeutic modalitiesClinical and experimental pharmacology & physiology. PMID 32064656 · doi:10.1111/1440-1681.13282
- 2016. Laūq: A Sustained-Release Dosage Form for Respiratory Disorders in Traditional Persian MedicineJournal of evidence-based complementary & alternative medicine. PMID 26008751 · doi:10.1177/2156587215587417
- 2012. Pharmacological potentials of Cassia auriculata and Cassia fistula plants: A reviewPakistan journal of biological sciences : PJBS. PMID 24163950 · doi:10.3923/pjbs.2012.408.417
- 2010. A review of the efficacy of traditional Iranian medicine for inflammatory bowel diseaseWorld journal of gastroenterology. PMID 20857519 · doi:10.3748/wjg.v16.i36.4504
- 2002. Common environmental allergens causing respiratory allergy in IndiaIndian journal of pediatrics. PMID 12003301 · doi:10.1007/BF02734234
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.